ArticleMicrobial biotechnology2025
Subcellular Mechanisms of Se(IV) Reduction in Stenotrophomonas bentonitica: Linking Environmental Detoxification and Antimicrobial Activity of Se Nanostructures Within a Circular Economy Framework.
Article in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Selenium: From Redox Signaling to Interactions with the Gut Microbiome.Biological trace element research · 2026Review
- Biogenic synthesis and transcriptomic insights into selenium nanoparticle formation by Lactiplantibacillus plantarum SMB14 isolated from goat manure.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Selenium (Se) is an essential trace element whose toxicity depends on its oxidation state. Microorganisms detoxify Se(VI) and Se(IV) by reducing them to elemental selenium [Se(0)], forming selenium nanoparticles (SeNPs) with antimicrobial activity. Stenotrophomonas bentonitica BII-R7 exhibits remarkable tolerance and reduction capacity toward toxic Se oxyanions, making it a promising candidate for bioremediation and green nanotechnology. In this study, cells exposed to Se(IV) were fractionated into cytoplasmic and membrane components and analysed at 24, 168 and 720 h. Spherical SeNPs were observed in the cytoplasm, while irregular aggregates formed in the membrane fraction, suggesting compartment-specific reduction pathways. The delayed formation of SeNPs in membranes supports a time-dependent, multimodal mechanism. Homogeneous biogenic SeNPs (160-180 nm) produced by intact S. bentonitica cells exhibited antimicrobial activity against Escherichia coli CET101 and Staphylococcus aureus ATCC 25923. Flow cytometry revealed strong, time-dependent cytotoxicity. In E. coli, SeNPs induced 21.1% membrane depolarization, 62.8% ROS accumulation and DNA damage at 48 h, indicating a ROS-mediated mechanism. In contrast, S. aureus showed early membrane depolarization at 12 h, with only 4.37% active cells and minimal ROS levels, and a significant drop in viability at 24 h (31.3%), suggesting a ROS-independent mechanism driven by membrane disruption. These findings highlight the strain-specific toxicity of SeNPs and their potential as eco-friendly, broad-spectrum antimicrobials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.